Clinical Trial Update: Long Acting Subcutaneous vs Short Acting Sublingual Buprenorphine in Pregnant and Lactating Women [Phase 4]

View source ↗

Summary

Phase 4 trial comparing long-acting subcutaneous buprenorphine to short-acting sublingual buprenorphine in pregnant and lactating women with opioid use disorder…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder

Drugs mentioned

• buprenorphine (buprenorphine)

Snippet

Sponsor: Ohio State University | Conditions: Opioid Use Disorder | Phase 4 | Status: WITHDRAWN